Valuation (38%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 105.09 | 16.35 |
PEG Ratio (TTM) | -6.66 | 1.68 |
P/S Ratio (TTM) | 3.63 | 2.61 |
P/B Ratio (TTM) | 1.57 | 1.91 |
P/FCF Ratio (TTM) | 49.06 | 11.19 |
Price to 5YR AVG Earnings Ratio | 27.19 | 14.05 |
Price to 5YR AVG FCF Ratio | 21.37 | 8.11 |
Profitability (20%) |
Company | Industry |
---|---|---|
ROA (TTM) | 0.15% | 1,504.35% |
ROE (TTM) | 1.54% | 8.89% |
Net Profit Margin (TTM) | 3.35% | 15.63% |
ROIC 5YR AVG | 5.14% | 20.58% |
Growth (97%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 95.72% | 73.45% | 31.24% |
Revenue | 28.19% | 13.78% | 18.50% |
Net Income | 95.92% | 68.58% | 28.25% |
Cash Flow | 7.22% | 54.50% | 27.24% |
Health (32%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.12 | 3.17 |
Quick Ratio (TTM) | 0.12 | 4.87 |
D/E Ratio (TTM) | 1.32 | 1.27 |
Interest Coverage (TTM) | 0.14 | 0.64 |
Piotroski F-Score | 7 | 6 |
Altman Z-Score | N/A | 0.38 |
LTL to 5YR AVG FCF | 7.60 | 6.38 |
Shares Outstanding Growth 5YR AVG | -1.60% | 4.83% |